Related Experiment Video
Updated: May 15, 2026

Harnessing the Power of MicroRNA Cargoes in Small Extracellular Vesicles Released from Fresh-Frozen Human Brain Sections
Published on: November 8, 2024
microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF)
Peter N Alexandrov1, Prerna Dua, James M Hill
1Russian Academy of Medical Sciences Moscow 113152, Russia.
Abstract:
Human cerebrospinal fluid (CSF), produced by the choroid plexus and secreted into the brain ventricles and subarachnoid space, plays critical roles in intra-cerebral transport and the biophysical and immune protection of the brain. CSF composition provides valuable insight into soluble pathogenic bio-markers that may be diagnostic for brain disease. In these experiments we analyzed amyloid beta (Aβ) peptide and micro RNA (miRNA) abundance in CSF and in short post-mortem interval (PMI <2.1 hr) brain tissue-derived extracellular fluid (ECF) from Alzheimer's disease (AD) and age-matched control neocortex. There was a trend for decreased abundance of Aβ42 in the CSF and ECF in AD but it did not reach statistical significance (mean age ~72 yr; N=12; p~0.06, ANOVA). The most abundant nucleic acids in AD CSF and ECF were miRNAs, and their speciation and inducibility were studied further. Fluorescent miRNA-array-based analysis indicated significant increases in miRNA-9, miRNA-125b, miRNA-146a, miRNA-155 in AD CSF and ECF (N=12; p<0.01, ANOVA). Primary human neuronal-glial (HNG) cell co-cultures stressed with AD-derived ECF also displayed an up-regulation of these miRNAs, an effect that was quenched using the anti-NF-кB agents caffeic acid phenethyl ester (CAPE) or 1-fluoro-2-[2-(4-methoxy-phenyl)-ethenyl]-benzene (CAY10512). Increases in miRNAs were confirmed independently using a highly sensitive LED-Northern dot-blot assay. Several of these NF-кB-sensitive miRNAs are known to be up-regulated in AD brain, and associate with the progressive spreading of inflammatory neurodegeneration. The results indicate that miRNA-9, miRNA-125b, miRNA-146a and miRNA-155 are CSF- and ECF-abundant, NF-кB-sensitive pro-inflammatory miRNAs, and their enrichment in circulating CSF and ECF suggest that they may be involved in the modulation or proliferation of miRNA-triggered pathogenic signaling throughout the brain and central nervous system (CNS).
Insights
Alzheimer's disease (AD) shows increased levels of specific microRNAs (miRNAs) in cerebrospinal fluid (CSF) and brain extracellular fluid (ECF). These NF-κB-sensitive miRNAs may drive inflammatory neurodegeneration in the central nervous system (CNS).
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Cerebrospinal fluid (CSF) composition offers insights into brain disease biomarkers.
- Alzheimer's disease (AD) is characterized by complex pathological changes in the brain.
Purpose of the Study:
- To analyze amyloid beta (Aβ) peptide and microRNA (miRNA) abundance in CSF and extracellular fluid (ECF) from AD patients.
- To investigate the role of specific miRNAs in AD pathogenesis and neuroinflammation.
Main Methods:
- Analysis of Aβ peptide and miRNA levels in human CSF and brain ECF using miRNA-array and LED-Northern assays.
- Co-culture experiments with human neuronal-glial (HNG) cells exposed to AD-derived ECF.
- Treatment of HNG cells with anti-NF-κB agents to assess miRNA regulation.
Main Results:
- A trend for decreased Aβ42 abundance was observed in AD CSF and ECF, but not statistically significant.
- Significant increases in specific miRNAs (miRNA-9, miRNA-125b, miRNA-146a, miRNA-155) were found in AD CSF and ECF.
- AD-derived ECF induced up-regulation of these miRNAs in HNG cells, which was inhibited by anti-NF-κB agents.
Conclusions:
- Specific miRNAs (miRNA-9, miRNA-125b, miRNA-146a, miRNA-155) are elevated in AD CSF and ECF.
- These miRNAs are NF-κB-sensitive and pro-inflammatory, suggesting a role in AD-associated neuroinflammation.
- Enrichment of these miRNAs in CSF and ECF may contribute to the spread of pathogenic signaling in the CNS.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
MicroRNAs
MicroRNAs

